• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重正常、超重和肥胖的无症状代谢健康韩国成年人中,正常收缩压维持情况与冠状动脉钙化进展风险的评估

Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity.

作者信息

Won Ki-Bum, Choi Su-Yeon, Chun Eun Ju, Park Sung Hak, Sung Jidong, Jung Hae Ok, Chang Hyuk-Jae

机构信息

Division of Cardiology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang 10326, Republic of Korea.

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul 03722, Republic of Korea.

出版信息

J Clin Med. 2023 May 31;12(11):3770. doi: 10.3390/jcm12113770.

DOI:10.3390/jcm12113770
PMID:37297965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10253414/
Abstract

Metabolically healthy obesity (MHO) is known to have a close association with subclinical coronary atherosclerosis. Despite recent data on the benefit of intensive systolic blood pressure (SBP) control in diverse clinical conditions, little is known regarding the association of normal SBP maintenance (SBP) with coronary artery calcification (CAC) progression in MHO. This study included 2724 asymptomatic adults (48.8 ± 7.8 years; 77.9% men) who had no metabolic abnormalities except overweight and obesity. Participants with normal weight (44.2%), overweight (31.6%), and obesity (24.2%) were divided into two groups: normal SBP (follow-up SBP < 120 mm Hg) and ≥elevated SBP (follow-up SBP ≥ 120 mm Hg). CAC progression was defined using the SQRT method, a difference of ≥2.5 between the square root (√) of the baseline and follow-up coronary artery calcium score. During a mean follow-up of 3.4 years, the proportion of normal SBP (76.2%, 65.2%, and 59.1%) and the incidence of CAC progression (15.0%, 21.3%, and 23.5%) was different in participants with normal weight, overweight, and obesity (all < 0.05, respectively). The incidence of CAC progression was lower in the normal SBP group than in the ≥elevated SBP group in only participants with obesity (20.8% vs. 27.4%, = 0.048). In multiple logistic models, compared to participants with normal weight, those with obesity had a higher risk of CAC progression. Normal SBP was independently associated with the decreased risk of CAC progression in participants with obesity. MHO had a significant association with CAC progression. Normal SBP reduced the risk of CAC progression in asymptomatic adults with MHO.

摘要

代谢健康型肥胖(MHO)与亚临床冠状动脉粥样硬化密切相关。尽管近期有数据表明在不同临床情况下强化收缩压(SBP)控制有益,但关于MHO患者维持正常SBP与冠状动脉钙化(CAC)进展之间的关联却知之甚少。本研究纳入了2724名无症状成年人(48.8±7.8岁;77.9%为男性),他们除超重和肥胖外无代谢异常。体重正常者(44.2%)、超重者(31.6%)和肥胖者(24.2%)被分为两组:正常SBP组(随访SBP<120mmHg)和SBP升高组(随访SBP≥120mmHg)。CAC进展采用SQRT方法定义,即基线和随访冠状动脉钙化积分的平方根(√)之差≥2.5。在平均3.4年的随访期间,体重正常、超重和肥胖参与者的正常SBP比例(分别为76.2%、65.2%和59.1%)以及CAC进展发生率(分别为15.0%、21.3%和23.5%)存在差异(均P<0.05)。仅在肥胖参与者中,正常SBP组的CAC进展发生率低于SBP升高组(20.8%对27.4%,P=0.048)。在多因素逻辑模型中,与体重正常的参与者相比,肥胖者发生CAC进展的风险更高。正常SBP与肥胖参与者CAC进展风险降低独立相关。MHO与CAC进展显著相关。正常SBP降低了MHO无症状成年人CAC进展的风险。

相似文献

1
Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity.体重正常、超重和肥胖的无症状代谢健康韩国成年人中,正常收缩压维持情况与冠状动脉钙化进展风险的评估
J Clin Med. 2023 May 31;12(11):3770. doi: 10.3390/jcm12113770.
2
Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.在没有既定心血管疾病的情况下,维持正常收缩压与冠状动脉粥样硬化的纵向定量评估。
Clin Cardiol. 2022 Aug;45(8):873-881. doi: 10.1002/clc.23870. Epub 2022 Jun 8.
3
Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study.代谢健康型肥胖与冠状动脉钙化的患病率和进展的相关性:来自 Heinz Nixdorf 回顾性队列研究的结果。
Nutr Metab Cardiovasc Dis. 2019 Mar;29(3):228-235. doi: 10.1016/j.numecd.2018.11.002. Epub 2018 Nov 15.
4
Metabolically-healthy obesity and coronary artery calcification.代谢健康型肥胖与冠状动脉钙化。
J Am Coll Cardiol. 2014 Jun 24;63(24):2679-86. doi: 10.1016/j.jacc.2014.03.042. Epub 2014 Apr 30.
5
Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.肥胖的不同代谢表型与冠状动脉钙化进展及心血管疾病事件发生风险:CARDIA研究
Arterioscler Thromb Vasc Biol. 2022 May;42(5):677-688. doi: 10.1161/ATVBAHA.122.317526. Epub 2022 Apr 7.
6
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.非酒精性脂肪肝疾病在代谢健康肥胖人群中决定了冠状动脉钙化的进展。
PLoS One. 2017 Apr 18;12(4):e0175762. doi: 10.1371/journal.pone.0175762. eCollection 2017.
7
Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis.代谢健康型肥胖与冠状动脉钙化风险升高的关联:一项系统评价与荟萃分析
PeerJ. 2020 Mar 26;8:e8815. doi: 10.7717/peerj.8815. eCollection 2020.
8
Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.糖尿病与冠状动脉钙:1 型糖尿病冠状动脉钙化研究(CACTI)。
Diabetes Technol Ther. 2011 Oct;13(10):991-6. doi: 10.1089/dia.2011.0046. Epub 2011 Jul 19.
9
Progression of subclinical coronary atherosclerosis: does obesity make a difference?亚临床冠状动脉粥样硬化的进展:肥胖有影响吗?
Circulation. 2005 Apr 19;111(15):1877-82. doi: 10.1161/01.CIR.0000161820.40494.5D.
10
Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline.甘油三酯葡萄糖指数是基线时无重度冠状动脉钙化的情况下冠状动脉钙化进展的独立预测因子。
Cardiovasc Diabetol. 2020 Mar 16;19(1):34. doi: 10.1186/s12933-020-01008-5.

本文引用的文献

1
Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.肥胖症及其合并症的评估与治疗:韩国肥胖研究学会2022年肥胖临床实践指南更新
J Obes Metab Syndr. 2023 Mar 30;32(1):1-24. doi: 10.7570/jomes23016. Epub 2023 Mar 22.
2
An update on the coronary calcium score: a review for clinicians.冠状动脉钙化积分最新进展:临床医生综述
Postepy Kardiol Interwencyjnej. 2022 Sep;18(3):201-205. doi: 10.5114/aic.2022.121035. Epub 2022 Dec 23.
3
Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology.
冠状动脉钙化筛查在评估动脉粥样硬化性心血管疾病风险中的演变及其在预防心脏病学中的作用。
Curr Atheroscler Rep. 2022 Dec;24(12):949-957. doi: 10.1007/s11883-022-01073-z. Epub 2022 Nov 14.
4
Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.在没有既定心血管疾病的情况下,维持正常收缩压与冠状动脉粥样硬化的纵向定量评估。
Clin Cardiol. 2022 Aug;45(8):873-881. doi: 10.1002/clc.23870. Epub 2022 Jun 8.
5
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.老年高血压患者强化血压控制试验。
N Engl J Med. 2021 Sep 30;385(14):1268-1279. doi: 10.1056/NEJMoa2111437. Epub 2021 Aug 30.
6
2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea.《2020年韩国肥胖研究学会韩国肥胖管理指南》
J Obes Metab Syndr. 2021 Jun 30;30(2):81-92. doi: 10.7570/jomes21022.
7
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的试验最终报告。
N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281.
8
Sex differences in coronary artery calcium progression: The Korea Initiatives on Coronary Artery Calcification (KOICA) registry.冠状动脉钙进展的性别差异:韩国冠状动脉钙化倡议 (KOICA) 登记研究。
PLoS One. 2021 Apr 8;16(4):e0248884. doi: 10.1371/journal.pone.0248884. eCollection 2021.
9
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.KDIGO 2021慢性肾脏病血压管理临床实践指南
Kidney Int. 2021 Mar;99(3S):S1-S87. doi: 10.1016/j.kint.2020.11.003.
10
Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease.有冠心病家族史人群中冠状动脉钙评分的成本效益。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1206-1217. doi: 10.1016/j.jcmg.2020.11.008. Epub 2021 Jan 13.